Company news
Devonian Health Group, Inc. (TSXV:GSD) news
Every Devonian Health Group, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Devonian Health Group Strengthens Thykamine™ Manufacturing Platform with Validated Chemical-Composition Fingerprinting and Biological Pot...
September 1, 2026
Devonian Health Group Anticipates to Commence Trading on the NYSE American
August 18, 2026
Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
July 27, 2026
Devonian Health Group Receives Health Canada Authorization to Initiate Phase II/III Pediatric Clinical Trial of Thykamine™ for Mild-to-Mo...
July 21, 2026
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
June 29, 2026
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
March 25, 2026
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine(TM), with Dose-Dependent Anti-...
February 19, 2026
Devonian Advances Thykamine(TM) Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls
February 17, 2026
Devonian reports additional molecular data from MASH liver study
February 12, 2026
DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY
February 10, 2026
DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT
February 2, 2026
DEVONIAN ANNOUNCES SHARE CONSOLIDATION IN FURTHER PREPARATION FOR POTENTIAL U.S. LISTING
January 20, 2026
Devonian Health Group Announces Grant of Stock Options
December 19, 2025
Devonian Health Group Reports Financial Results of its First Quarter Ended on October 31, 2025 and Provides Corporate Update
December 12, 2025
Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine™ as a Promising New Anti-Inflammatory Agent
December 4, 2025
Devonian Health Group Announces Publication of Landmark Study Highlighting Thykamine(TM) as a Promising New Anti-Inflammatory Agent
December 4, 2025
Devonian Health Group Reports its Fourth Quarter and Annual 2025 Financial Results and Appointment of a New Board Member
November 26, 2025
Devonian Health Group Inc. announces its participation to the ThinkEquity Conference in New York and closing of a Non-Brokered Private Pl...
October 22, 2025
Devonian Provides Corporate Update and Additional Information Regarding its Previously Announced Private Placement
August 22, 2025
Devonian Announces Closing of a Private Placement of Units
August 7, 2025
Devonian Health Group Reports Third Quarter 2025 Financial Results
June 26, 2025
Devonian Appoints New Officers and Announces Grant of Stock Options
June 9, 2025
Canadian Investment Regulatory Organization Trade Resumption - GSD
April 29, 2025
Devonian Health Group Announces Reinstatement of Quotation on the TSXV
April 28, 2025
Devonian Health Group Reports Second Quarter 2025 Financial Results
April 15, 2025
Devonian Health Group Reports Cease Trade Order
April 14, 2025
Canadian Investment Regulatory Organization Trading Halt - GSD
April 8, 2025
Devonian Reports Delay of Financial Reporting
April 1, 2025
Devonian Reports Results of its Annual General and Special Meeting of Shareholders
March 24, 2025
Devonian Announces the Filing of a New Patent Application Relating to the Use of Thykamine™ as an Antifibrotic Agent
February 19, 2025
Devonian Announces the Filing of a New Patent Application Relating to the Use of Thykamine(TM) as an Antifibrotic Agent
February 19, 2025
Devonian Announces Positive in Vivo Results of Thykamine™ on Gene Expression Associated With Fibrosis
February 18, 2025
Devonian Announces Positive in Vivo Results of Thykamine(TM) on Gene Expression Associated With Fibrosis
February 18, 2025
Devonian Announces the Filing of a New Provisional Patent Application Relating to the Use of Thykamine(TM) for Treating Metabolic Dysfunc...
February 13, 2025
Devonian Reports Positive Results in MASH Liver Study
February 13, 2025
Devonian Reports Distribution Agreement Termination
February 7, 2025
IIROC Trading Resumption - GSD
February 26, 2018
IIROC Trade Resumption - Devonian Health Group Inc.
February 26, 2018
IIROC Trading Halt - GSD
January 31, 2018
IIROC Trade Halt - Devonian Health Group Inc.
January 31, 2018
InvestmentPitch Media Invites Investors to the GCFF Conference in Toronto on September 30, 2017 - Video Hosted on InvestmentPitch.com
September 28, 2017
IIROC Trade Halt - Orletto Capital Inc.
May 20, 2015
IIROC Trading Halt - OLE.P
May 20, 2015
IIROC Trading Resumption - OLE.P
September 9, 2014
IIROC Trade Resumption - Orletto Capital Inc.
September 9, 2014